Table 3.
Optical density in crystal violet assay of Streptococcus mutans and Candida albicans mixed biofilm according to the treatment
Treatment | Optical density (at 570 nm) | |||||
---|---|---|---|---|---|---|
C1 | C2 | Negative control | ||||
Mean | SD | Mean | SD | Mean | SD | |
Chlorhexidine | 0.180ABC | 0.036 | 0.181AB | 0.050 | 0.416 | 0.074 |
Nystatin | 0.218AC | 0.044 | 0.228AB | 0.068 | 0.416 | 0.074 |
Chlorhexidine/30 min/nystatin | 0.210A | 0.031 | 0.240AB | 0.089 | 0.373 | 0.167 |
Nystatin/30 min/chlorhexidine | 0.199AC | 0.030 | 0.241A | 0.052 | 0.373 | 0.167 |
Chlorhexidine/1 min/nystatin | 0.161BC | 0.013 | 0.153B | 0.021 | 0.352 | 0.173 |
Nystatin/2 min/chlorhexidine | 0.143B | 0.014 | 0.144B | 0.014 | 0.352 | 0.173 |
Chlorhexidine/10 min/nystatin | 0.191AC | 0.027 | 0.192AB | 0.053 | 0.442 | 0.189 |
Nystatin/10 min/chlorhexidine | 0.191AC | 0.027 | 0.192AB | 0.053 | 0.442 | 0.189 |
Chlorhexidine/nystatin single | 0.168ABC | 0.021 | 0.172AB | 0.020 | 0.474 | 0.180 |
P* | 0.000 | 0.000 |
C1 2 μg/mL chlorhexidine and 1 μg/mL nystatin, C2 1 μg/mL chlorhexidine and 0.5 μg/mL nystatin. SD standard deviation
*P value for ANOVA comparing the treatments within each concentration; means followed by different letters in the same column differ significantly (α = 0.05) by Dunnett’s T3 multiple comparisons test
Negative control mixed biofilm without drugs; not included in the statistical analysis